Ann‐Sofie Jemth
- Oncology top 5%
- PARP inhibition in cancer therapy 6
- Molecular Biology top 5%
- DNA Repair Mechanisms 14
- Biochemical and Molecular Research 14
- RNA modifications and cancer 6
- ATP Synthase and ATPases Research 4
- Mitochondrial Function and Pathology 2
- Physiology top 5%
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
-
- Enzyme Structure and Function 5
- Co-authors
- Thomas HelledayOlga LosevaHelen E. BryantPål StenmarkNatalia IssaevaNiklas SchultzSerena FernandezPeter McGlynn
- Cited by
- OncologyMolecular BiologyPhysiology
- Journals
- Journal of Biological Chemistry (6 papers)Cancer Research (3 papers)FEBS Letters (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Ann‐Sofie Jemth
34 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 87
- Oncology 813
- Molecular Biology 1.4k
- Physiology 90
- Cancer Research 196
- Immunology 202
Countries citing papers authored by Ann‐Sofie Jemth
This map shows the geographic impact of Ann‐Sofie Jemth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Sofie Jemth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Sofie Jemth more than expected).
Fields of papers citing papers by Ann‐Sofie Jemth
This network shows the impact of papers produced by Ann‐Sofie Jemth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Sofie Jemth. The network helps show where Ann‐Sofie Jemth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann‐Sofie Jemth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 14 | |
| 3 | 2021 | 5 | |
| 4 | 2020 | 24 | |
| 5 | 2020 | 16 | |
| 6 | 2019 | 6 | |
| 7 | 2018 | 23 | |
| 8 | 2018 | 5 | |
| 9 | 2018 | 11 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 5 | |
| 12 | 2017 | 18 | |
| 13 | 2017 | 6 | |
| 14 | 2016 | 71 | |
| 15 | 2016 | 35 | |
| 16 | 2014 | 299 | |
| 17 | 2011 | 67 | |
| 18 | 2010 | 131 | |
| 19 | Evolutionary design of glutathione-linked proteins in vivo and in vitro based on sampling of modules from pre-existing structures | 2001 | 1 |
| 20 | Ser11 plays several roles in the catalytic mechanism of rat glutathione transferase T2-2 | 2001 | 1 |
About Ann‐Sofie Jemth
Ann‐Sofie Jemth is a scholar working on Molecular Biology, Cancer Research and Clinical Biochemistry, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (14 papers), Biochemical and Molecular Research (14 papers), RNA modifications and cancer (6 papers), PARP inhibition in cancer therapy (6 papers), Enzyme Structure and Function (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), ATP Synthase and ATPases Research (4 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Oncology (813 citations), Molecular Biology (1.4k citations) and Physiology (90 citations). Ann‐Sofie Jemth has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Thomas Helleday, Olga Loseva, Helen E. Bryant, Pål Stenmark, Natalia Issaeva, Niklas Schultz, Serena Fernandez, Peter McGlynn, Fredrik Johansson and Eva Petermann. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, FEBS Letters, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.